03/09/22 Akorn Announces Completion of the Sale of its Branded Ophthalmic Products to Théa Pharma
05/27/21 Akorn Announces Agreement to Sell its Consumer Health Business to Prestige Consumer Healthcare
05/10/21 Akorn Announces Two Key Executive Appointments
02/26/21 Akorn Announces Review of Strategic Alternatives for the Akorn Consumer Health Business
02/11/21 Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Gel, 0.5%

Events Events

Date Title Download
No upcoming events scheduled. Please check back.

Annual Reports Media Contact

Please direct all media inquiries to